News & Announcements

New Publications by Ibis Staff

Archive

August 2006

• FDA approves Plan B over-the-counter emergency contraception for women 18 and older:
  • View Ibis's press release.
  • View the FDA's press release.
  • View the Reproductive Health Technologies Project's press release.
  • View Barr Laboratories' press release
• New study by Ibis, NAF, and AAP shows abortion-care education is deficient in U.S. health professional training. (View press release.)

January 2006

• Complying with the Law? How Catholic hospitals respond to state laws mandating the provision of emergency contraception to sexual assault patients. (View press release.)
• Arabic-English bilingual guide to medication abortion. " Medication abortion: A guide for health professionals" provides an overview of the mifepristone/misoprostol, methotrexate/misoprostol, and the misoprostol-only regimens, including information about protocols, efficacy and safety, eligibility and contraindications, side effects and complications, and acceptability. Copies of the reader can be obtained by request and PDF versions of the reader are available in both Arabic and English.
• Microbicides 2006 Conference

November 2005

• Kelly Blanchard, Ibis's New President.

June 2005

• South Africa Emergency Contraception Strategy Meeting.
• The Spanish version of our medication abortion website

July 2005

• Studies of Emergency Contraception Web Sites Demonstrate Stark Need for On-line Reproductive Health Information. (View Press release.)

May 2005

• Study finds EC access limited at hospitals. (Press release.)

April 2005

• Report by NNAF and Ibis documents hardships and delays caused by bans on public funding of abortion.

March 2005

• Ibis featured in article: Sex machinery Massachusetts is at the forefront of cutting-edge sex research. Who knew

February 2005

• Rachel Roth of Ibis collaborated with Palak Shah of PRA on a chapter about the intersection of reproductive rights and criminal justice policies in the U.S. A fact sheet about women in the criminal justice and prison systems is also available. Visit www.defendingjustice.org to see the entire project, Defending Justice: An Activist Resource Kit, published by Political Research Associates.

January 2005

• The Center for Reproductive Rights filed a lawsuit in federal court in New York on behalf of several individual plaintiffs challenging the FDA's ongoing denial of OTC status for Plan B. The lawsuit seeks an injunction ordering the FDA to approve the OTC switch for women of all ages. The complaint in the case asserts that the FDA's failure to approve the OTC switch violates the federal statute governing actions by federal administrative agencies, violates the constitutional privacy rights of women seeking EC, and constitutes impermissible sex discrimination because EC is used only by women.
  
  The Center’s website is http://www.crlp.org/

December 2004

• SAfAIDS feature article by Ibis Reseachers "A Potential New Role for Cervical Barrier Methods" (pdf)

August 2004

• Ibis Reproductive Health and the Reproductive Health Technologies Project have developed a fact sheet that presents current data on the spermicide Nonoxynol-9.

July 2004

• Ibis Reproductive Health introduces CBAS -- Ibis Reproductive Health launches the Cervical Barrier Advancement Society (CBAS), an international networking organization for professionals in the reproductive health and HIV/AIDS communities. CBAS aims to raise the profile of cervical barrier methods for preventing pregnancy and potentially also HIV and other sexually transmitted infections. The CBAS website contains information about cervical barriers, research updates, downloadable materials, and images of cervical barriers. CBAS also publishes a newsletter several times a year.
• Ibis researchers publish article that considers female-initiated birth control methods that protect against pregnancy and sexually transmitted infections (STIs), including HIV. View the article.

April 2004

• On March 15th, Ibis, Family Health International and the Harvard Center for Population and Development Studies co-hosted a meeting of reproductive health experts to discuss strategies for making oral contraceptives (OCs) available over-the-counter (OTC). Participants reviewed the main arguments for and against making OCs OTC and there was a general consensus that whether or not OCs are sold OTC or as prescription products, compliance could be improved with better package labeling. New labeling would include a briefer list of evidence-based contraindications, as well as simpler instructions on initiating OCs and handling missed pills. Ibis intends to organize another meeting to review the evidence and build consensus around simplified labeling for OCs.
• Ibis releases first quarterly newsletter (word).
• Article clarifies relationship between oral contraceptives and cervical cancer.
  • Letter (pdf)
  • Article (pdf)